Chronic Graft Versus Host Disease Terminated Phase 2 Trials for Entospletinib (DB12121)

Also known as: GVHD, Chronic / CGVHD / Chronic GVHD / Chronic Graft-Versus Host Disease / Chronic Graft-Versus-Host-Disease / Chronic Graft vs. Host Disease / Chronic Graft-vs.-Host Disease / Chronic Graft vs Host Disease / Chronic Graft-Versus-Host Disease / Chronic GVH disease

IndicationStatusPhase
DBCOND0039599 (Chronic Graft Versus Host Disease)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02701634Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)Treatment